News
The combination of antifibrotic therapy and pulmonary vasodilator therapy improved transplant-free survival but had no ...
Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male ...
AbbVie's Emrelis is the first non-small cell lung cancer therapy approved for patients with high c-Met expression levels who ...
American depository receipts of Immutep rose after the company reported positive results from a trial of its combination treatment for non-small cell lung cancer. Immutep climbed 16% to $2.11 on ...
When you are diagnosed with COPD, it is important to remember that you are not alone. A healthcare team, which may include a ...
Vaping is especially popular among teenagers and young adults, but fruity, candy-like flavours come with a chemical cost ...
During a live event, Xiuning Le, MD, PhD, discussed clinical trials of supportive care for infusion reaction and skin rash ...
The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...
Emrelis is the first FDA-approved treatment for previously treated patients with locally advanced or metastatic non-squamous ...
KARACHI: Health experts have reported a concerning increase in cases of a lung disease linked to exposure to pigeons, ...
9h
Zacks.com on MSNAbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung CancerFollowing the approval, ABBV's Emrelis becomes the first FDA-approved therapy for previously treated advanced NSCLC patients ...
Discover when coughing up blood requires emergency medical care. Learn the causes, warning signs, and critical first steps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results